Therapeutics Today

TT Index

The Therapeutics Today newsletters that were published more that 2 years ago are now archived.

Recent Therapeutics Today newsletters can be found either below or they are available on request to nmic@stjames.ie

2026

September

• Guidance and Advice
• Regular features
• Signposting

August

• Guidance and Advice
• Regular features
• Signposting

July

• Guidance and Advice
• Regular features
• Signposting

June

• Guidance and Advice
• Regular features
• Signposting

May

• Guidance and Advice
• Regular features
• Signposting

April

• Guidance and Advice
• Regular features
• Signposting

March

• Update about the antibioticprescribing.ie website

March

• Guidance and Advice
• Regular features
• Signposting

February

• Guidance and Advice
• Regular features
• Signposting

January

• Guidance and Advice
• Regular features
• Signposting

2025

December

• Guidance and Advice
• Regular features
• Signposting

November

• Guidance and Advice
• Regular features
• Signposting

October

• Guidance and Advice
• Regular features
• Signposting

September

• Guidance and Advice
• Regular features
• Signposting

August

• Guidance and Advice
• Regular features
• Signposting

June/July

• Guidance and Advice
• Regular features
• Signposting

May

• Guidance and advice
• Regular features
• Signposting

April

• Guidance and advice
• Regular features
• Signposting

March

• Guidance and advice
• Regular features
• Signposting

February

• Guidance and advice
• Regular features
• Signposting

January

• Guidance and advice
• Regular features
• Signposting

2024

December

• Recent NMIC Bulletin
• Guidance and Advice
• Regular features
• Signposting

November

• Recent NMIC Bulletin
• Guidance and Advice
• Regular features
• Signposting

October

• Recent NMIC Bulletin
• Guidance and Advice
• Regular features
• Signposting

September

• Recent NMIC Bulletin
• Guidance and Advice
• Regular features
• Signposting

August

• Recent NMIC Bulletins
• Guidance and Advice
• Regular features
• Signposting

July

• Guidance and Advice
• HSE Antibiotic Prescribing
• Medication Safety Minutes
• Communicable Diseases
• Signposting

June

• Guidance and Advice
• Antibiotic Prescribing
• Medication Safety
• Regulatory Information
• Communicable Diseases
• SignPosting

May

• Risk of adverse events following the initiation of antihypertensives in older people with complex health needs
• New NMIC learning module on HSeLanD
• Age-related risk of serious fall events and opioid Analgesic Use
• Use of progestogens and the risk of intracranial meningioma

April

• Practical prescribing: proton pump inhibitors (PPIs)
• Results of NMIC survey 2024
• Prevalence of potentially medications among newly treated patients with type 2 diabetes mellitus (T2DM)
• Learning to swallow pills?
• Health Products Regulatory Authority (HPRA) update

March

• Practical prescribing - thiazides diuretics
• Correct storage of biological disease-modifying  anti-rheumatic drugs at home
• Drug-induced dermatomyositis
• Potentially inappropriate prescribing and potential prescribing omissions and their association with adverse drug reaction-related hospital admission

February

• Gabapentinoids in Ireland 2010 to 2020
• Medicine shortages
• NMIC publications survey 2024
• Crushed tablet administration for patients with dysphagia or enteral feeding

January

• Help shape our publications, your opinion counts – please take the NMIC Survey 2024
• Drug-drug interactions and risk of adverse drug reaction-related hospital admissions in the older population
• Emollients – comparison of lotions, creams, gels and ointment for childhood eczema
• Safety outcomes when switching between biosimilar and reference biological medicines

2023

December

• Sharing prescription medications
• "Weekend warrior” physical activity & incident cardiovascular disease
• Breastfeeding & the incidence of infant illness in Ireland
• Primary prevention of CVD of Mediterranean diet in women

November

• Risk of Gastrointestinal Adverse Events Associated with GLP-1 Receptor Agonists for Weight Loss
• Paediatric ADHD medication errors reported to US poison Centres
• Managing drugs with anticholinergic activity

October

• Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs.
• Prevalence and predictors of primary non-adherence in primary care
• Aspirin for secondary prevention of cardiovascular disease

September

• Folic acid supplementation to prevent neural tube defects
• Association between daily step count and all-cause and cardiovascular mortality
• Cardiac and renal effects of sodium-glucose co-transporter 2 (SGLT2)

August

• Electrolyte disturbances due to proton pump inhibitors (PPIs)
• Vaccine hesitancy
• Familial hypercholesterolaemia (FH)

July

• COPD exacerbations and pneumonia hospitalisations among new users of combination maintenance inhalers.
• Health Products Regulatory Authority updates
• Polypharmacy and cumulative anticholinergic burden in older adults hospitalised with a fall
• Low-dose aspirin and risk of serious falls and fractures in healthy older people

June

• Bipolar disorder – monitoring drug interventions
• Trends in severe outcomes of adults and patients hospitalised with COVID -19
• Women’s pre-conception health in England

May

• Medication work among nonagenarians
• Use of pharmacy services in community-dwelling middle-age and older adults.
• NMIC useful medicines information resources webpage
• Oral anticoagulant safety audit
• Prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN).

April

• Breast cancer risk and contraception
• NMIC CPD module on HSeLanD!
• Prevention of hospital admissions for adverse drug reactions
• Withdrawing from SSRI antidepressants

March

• BRAINS & AIMS
• Further NMIC learning module on HSeLanD!
• Reduce unnecessary use of proton pump inhibitors (PPIs)
• Teachable moment – Paxlovid   avoiding drug-drug interactions
• Guideline updates

February

• Metabolic adverse events associated with systemic corticosteroid therapy
• Prevalence of drug-drug interactions in older adults in the community
• Values and preferences of patients and caregivers regarding eczema treatment
• Online eczema interventions to support self-care for children and young people
• Updated National Clinical Guidelines in Obstetrics and Gynaecology

January

• Adverse drug reactions in older people in the community in Ireland
• Thinking of a New Year’s resolution
• Gynaecomastia
• Glucocorticoid induced adrenal insufficiency (GC-AL)
• Regular Updates
• New Feature

2022

December

• Thank you very much!
• Morning versus evening antihypertensive medicine
• Health Products Authority (HPRA) Update
• Switching from a metered dose inhaler to a dry powder inhaler – effects on climate emissions and asthma control
• Effectiveness of physical activity interventions delivered or prompted by healthcare professionals in primary care
• NMIC Therapeutics Today 2022

November

• The revised isotretinoin pregnancy prevention programme: awareness, knowledge & implementation in practice of healthcare professionals.
• Risk of co-prescribing non-steroidal anti-inflammatory drugs and oral anticoagulants.
• Medicines Management Programme updates.
• Effectiveness of preconception care interventions in primary care.
• Paxlovid: update on prescribing and access

October

• ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.
• HSE-Medicines Management Programme Update
• Trends in direct oral anticoagulant prescribing in primary care in England
• Gastrointestinal bleeding risk after concomitant treatment with non-vitamin K oral anticoagulants and oral glucocorticoids.

September

• Obesity and oral emergency contraception
• Recent journal Articles on pregnancy
• Prescribing trends of antihypertensive medicines in the UK over 31 years
• Health Products Regulatory Authority updates
• HSeLanD Learning Module

August

• Adverse drug reactions, multimorbidity and polypharmacy
• Information resources for Ukrainian medicines
• NMIC useful information resources webpage update
• Medication Safety Minutes
• Guideline update

July Supplement

• Paxlovid : Update on prescribing and access
• Key safety Points
• Eligibility and prescribing considerations
• Drug-drug interactions
• Supply

July

• Opioids versus non-opioids following surgical discharge
• Further NMIC learning module on HSeLanD
• Management of Gout
• Guidance documents update

June

• Serotonin Syndrome
• Intramuscular injections in patients taking anticoagulant
• Guideline updates
• Drug reaction with eosinophilia and systemic symptoms (DRESS)
• Use of medications that may raise blood pressure

May

• Long-term nitrofurantoin therapy
• Health Products Regulatory Authority updates
• Guideline updates
• Montelukast and neuropsychiatric reactions
• Dose of paracetamol and low body weight
• Factors to consider when using medicines following bariatric surgery

April

• Sodium valproate (Epilim) utilisations trends in Ireland
• Emollients and risk of burns
• Non- vitamin K antagonist oral anticoagulants (NOACs) and pharmacokinetic drug interactions
• Examples of medicines that should be prescribed by brand name
• Guideline updates
• NMIC CPD modules on contraception
• Ukrainian Medicines Information Resources

March

• Paxlovid and risk of drug interactions
• Ireland’s second One Health National Action Plan (iNAP2) on Antimicrobial Resistance 2021-2025
• Regular Updates
• Measles

February

• Overactive bladder (OAB) in women
• Regular updates
• Patient adherence, satisfaction and knowledge of direct oral anticoagulants (DOACs)
• Impact of Gp-delivered medication review of older patients with multimorbidity and polypharmacy

January

• Associations of Statins adherence and lipid targets with adverse outcomes in patients following myocardial infarction
• Fatal adverse drug reactions
• Childhood constipation